Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia-Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006 Nov 15;15(2):131-8.
Svanes C, Zock JP, Anto J, Dharmage S, Norback D, Wjst M, Heinrich J, Jarvis D, de Marco R, Plana E. Do asthma and allergy influence subsequent pet keeping? An analysis of childhood and adulthood. J Allergy Clin Immunol. 2006 Sep;118(3):691-8.
Zock JP, Heinrich J, Jarvis D, Verlato G, Norback D, Plana E. Distribution and determinants of house dust mite allergens in Europe: the European community respiratory health survey II. J Allergy Clin Immunol. 2006 Sep;118(3):682-90.
Nyberg F, Hada S, Rothman KJ. Iressa and interstitial lung disease (ILD) in Japan - Lessons from a large nested case-control study to evaluate a safety issue. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.
Santanello NC, DeMuro-Mercon CJ, Shah SR, Schenkel EJ, Ratner PH, Norquist JM, Philip G. Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis. Allergy Asthma Proc. 2006 May 1;27(3):231-9.
Santanello NC, DeMuro-Mercon CJ, Shah SR, Schenkel EJ, Ratner PH, Dass B. Nighttime symptoms score provides clinically relevant measure of allergic rhinitis burden. Poster presented at the American Academy of Allergy, Asthma, and Immunology; March 2006. Miami Beach, FL.
Hopkinson NS, Eleftheriou KI, Payne J, Nickol AH, Hawe E, Moxham J, Montgomery H, Polkey MI. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 2006;83(4):912-7.
Rothman KJ. Causes and Risks. In: Clark MA, editors. Pulmonary disease. Defense mechanisms and populations at risk. Lexington: KY. Tobacco and Health Research Institute (THRI); 1977.